Lipids

Citations 101-110 of 396 total displayed.

Past content (since Feb 1999):

Articles Lipoprotein-Associated Phospholipase A₂ and Its Association With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) Trial: Michelle O’Donoghue, David A. Morrow, Marc S. Sabatine, Sabina A. Murphy, Carolyn H. McCabe, Christopher P. Cannon, and Eugene Braunwald
Circulation published March 14, 2006, doi:10.1161/CIRCULATIONAHA.105.612630 [Abstract]

Epidemiology
Dyslipidemia Prevalence, Treatment, and Control in the Multi-Ethnic Study of Atherosclerosis (MESA): Gender, Ethnicity, and Coronary Artery Calcium: David C. Goff, Jr, Alain G. Bertoni, Holly Kramer, Denise Bonds, Roger S. Blumenthal, Michael Y. Tsai, and Bruce M. Psaty
Circulation 2006;113:647-656, doi:10.1161/CIRCULATIONAHA.105.552737 [Abstract] [Full text]

Editorials
Coronary Artery Calcium: Should We Rely on This Surrogate Marker?: Rita F. Redberg
Circulation 2006;113:336-337, doi:10.1161/CIRCULATIONAHA.105.600676 [Full text]

Epidemiology
Increased Small Low-Density Lipoprotein Particle Number: A Prominent Feature of the Metabolic Syndrome in the Framingham Heart Study: Sekar Kathiresan, James D. Otvos, Lisa M. Sullivan, Michelle J. Keyes, Ernst J. Schaefer, Peter W.F. Wilson, Ralph B. D’Agostino, Ramachandran S. Vasan, and Sander J. Robins
Circulation 2006;113:20-29; published online before print as doi:10.1161/CIRCULATIONAHA.105.567107 [Abstract] [Full text]

Articles
Increased Small Low-Density Lipoprotein Particle Number. A Prominent Feature of the Metabolic Syndrome in the Framingham Heart Study: Sekar Kathiresan, James D. Otvos, Lisa M. Sullivan, Michelle J. Keyes, Ernst J. Schaefer, Peter W.F. Wilson, Ralph B. D’Agostino, Ramachandran S. Vasan, and Sander J. Robins
Circulation published December 27, 2005, doi:10.1161/CIRCULATIONAHA.105.567107 [Abstract]

Epidemiology
Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use: The Minnesota Heart Survey, 1980–1982 to 2000–2002: Donna K. Arnett, David R. Jacobs, Jr, Russell V. Luepker, Henry Blackburn, Christopher Armstrong, and Steven A. Claas
Circulation 2005;112:3884-3891; published online before print as doi:10.1161/CIRCULATIONAHA.105.549857 [Abstract] [Full text]

Pediatric Cardiology
Endothelial Function in Healthy 11-Year-Old Children After Dietary Intervention With Onset in Infancy: The Special Turku Coronary Risk Factor Intervention Project for Children (STRIP): Olli T. Raitakari, Tapani Rönnemaa, Mikko J. Järvisalo, Tuuli Kaitosaari, Iina Volanen, Katariina Kallio, Hanna Lagström, Eero Jokinen, Harri Niinikoski, Jorma S.A. Viikari, and Olli Simell
Circulation 2005;112:3786-3794; published online before print as doi:10.1161/CIRCULATIONAHA.105.583195 [Abstract] [Full text]

Articles
Twenty-Year Trends in Serum Cholesterol, Hypercholesterolemia, and Cholesterol Medication Use. The Minnesota Heart Survey, 1980-1982 to 2000-2002: Donna K. Arnett, David R. Jacobs, Jr, Russell V. Luepker, Henry Blackburn, Christopher Armstrong, and Steven A. Claas
Circulation published December 12, 2005, doi:10.1161/CIRCULATIONAHA.105.549857 [Abstract]

Articles
Endothelial Function in Healthy 11-Year-Old Children After Dietary Intervention With Onset in Infancy. The Special Turku Coronary Risk Factor Intervention Project for Children (STRIP): Olli T. Raitakari, Tapani Rönnemaa, Mikko J. Järvisalo, Tuuli Kaitosaari, Iina Volanen, Katariina Kallio, Hanna Lagström, Eero Jokinen, Harri Niinikoski, Jorma S.A. Viikari, and Olli Simell
Circulation published December 5, 2005, doi:10.1161/CIRCULATIONAHA.105.583195 [Abstract]

Editorials
Apolipoprotein B Versus Non–High-Density Lipoprotein Cholesterol: And the Winner Is...: Allan D. Sniderman
Circulation 2005;112:3366-3367, doi:10.1161/CIRCULATIONAHA.105.583336 [Full text]

Subspecialty Collections Home

Show Lipids
collections from other journals.